This post was originally published on this site
https://i-invdn-com.investing.com/trkd-images/LYNXMPEH9504E_L.jpg
A California jury found that the herbicide was not a substantial cause of a child’s rare form of non-Hodgkin’s lymphoma, the company said on Tuesday. The verdict is the fourth involving Roundup and the first in the company’s favor.
Roundup-related lawsuits have dogged Bayer (OTC:BAYRY) since it acquired the brand as part of its $63 billion purchase of agricultural seeds and pesticides maker Monsanto (NYSE:MON) in 2018.
